Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
AZIYO BIOLOGICS, INC. (AZYO)
|
|
Cash Flow Statement |
|
|
|
Standardized | As Reported |
Annual | Quarterly | TTM |
|
In millions, except per share items | Jun-30-23 | Mar-31-23 | Dec-31-22 | Sep-30-22 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Net income | -10.6 | -8.0 | -5.4 | -9.9 | -9.4 | -8.1 | -9.1 | -8.3 |
Depreciation and amortization | 1.0 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 |
Stock-based compensation | 0.7 | 0.7 | 0.8 | 0.3 | 1.5 | 1.1 | 1.0 | 1.0 |
Change in working capital [+] | 4.1 | 2.4 | 2.8 | -14.7 | 2.5 | -2.4 | 0.7 | 2.2 |
Accounts receivable | 0.2 | -0.5 | 0.3 | -0.5 | -0.6 | 0.0 | -0.5 | 2.2 |
Inventories | -0.2 | -1.0 | 0.1 | -0.5 | 0.2 | -0.3 | 0.3 | 0.5 |
Other current assets | 0.0 | 0.6 | -2.0 | 0.8 | 1.2 | -1.6 | -0.2 | 0.5 |
Other | 4.2 | 3.3 | 4.3 | -14.5 | 1.8 | -0.5 | 1.0 | -1.1 |
Other operating activities | 2.5 | -1.2 | -4.3 | 17.9 | 1.1 | 1.2 | 0.1 | 1.1 |
Cash from operations | -2.4 | -5.2 | -5.2 | -5.5 | -3.3 | -7.4 | -6.4 | -3.1 |
|
Capital expenditures | -0.1 | -0.2 | -0.1 | -0.1 | -0.3 | 0.0 | 0.0 | -0.1 |
Purchases of property and equipment | -0.1 | -0.2 | -0.1 | -0.1 | -0.3 | 0.0 | 0.0 | -0.1 |
Cash from investing | -0.1 | -0.2 | -0.1 | -0.1 | -0.3 | 0.0 | 0.0 | -0.1 |
|
Issuance of common stock, net | | | 10.2 | | | -0.1 | 13.8 | |
Option exercises | | 0.1 | 0.1 | 0.1 | | 0.2 | | 0.2 |
Financing costs | | | | -0.5 | | | | |
Other cash from financing | 0.0 | 0.3 | 4.1 | -3.1 | -2.1 | -0.6 | 0.5 | -2.3 |
Cash from financing | 0.0 | 0.1 | 14.3 | -2.8 | -2.1 | -0.9 | 14.2 | -2.5 |
|
Free cash flow | -2.5 | -5.3 | -5.4 | -5.6 | -3.6 | -7.4 | -6.4 | -3.2 |
Per share (diluted) | ($0.15) | ($0.33) | ($0.39) | ($0.41) | ($0.26) | ($0.54) | ($0.61) | ($0.31) |
|
Cash paid for interest | 0.5 | 0.6 | 0.4 | 3.9 | | 1.2 | 1.2 | 1.3 |
|